Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07409584 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Mental Health and Suicidality in Glioblastoma Patients in Germany

Study acronym: SHINE-GLIO
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Feb 28, 2027 → Mar 17, 2028
See other at-risk trials from University Hospital, Essen

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Feb 28, 2027 to Mar 17, 2028
    • Study completion pushed from Dec 1, 2027 to Dec 1, 2028
    • Enrollment target: 176 to 180
    • Eligibility criteria expanded, about 8 words
    v4
  2. Start date changed from estimate of Mar 19, 2026 to Mar 18, 2026v3
  3. Recruitment opened
    • Start date: Mar 1, 2026 to Mar 19, 2026
    • Site details revised at 6 of 6 sites
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
University Hospital, Essen
35 trials monitored
See 1 trial at risk
Glioma
1,251 trials monitored
See 88 trials at risk
Glioblastoma
710 trials monitored
See 52 trials at risk
The aim of the study is to use standardized questionnaires to systematically record influencing factors or predictors for suicidal behavior in glioblastoma patients, particularly with regard to existing depression and anxiety symptoms.
Trial Details
NCT Number NCT07409584
Lead Sponsor University Hospital, Essen
Collaborators: University Hospital Muenster, Charite University, Berlin, Germany, University Hospital Heidelberg, Neurological Clinic, Knappschaftskrankenhaus Bochum-Langendreer, Bochum, Germany, Universitätsklinikum Hamburg-Eppendorf
Conditions
(from sponsor)		 Glioblastoma (GBM)
Related terms Depression, Glioblastoma, Suicidal Ideation
Enrollment 180 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov